| 序号 | 专利名 | 申请号 | 申请日 | 公开（公告）号 | 公开（公告）日 | 发明人 |
|---|---|---|---|---|---|---|
| 1 | 用于治疗和/或预防天然AHR配体依赖性癌症的手段和方法 | CN201280043522.9 | 2012-09-07 | CN104023713A | 2014-09-03 | M·普拉滕; C·奥皮茨; W·维克; U·利岑贝格 |
| 本发明涉及癌症疗法和癌症治疗的领域。特别地，本发明涉及用于治疗和／或预防天然AHR配体依赖性癌症的方法，其包括向患有所述癌症的受试者施用治疗有效量的AHR抑制剂。而且，本发明还涉及AHR抑制剂用于治疗和／或预防天然AHR配体依赖性癌症。 | ||||||
| 2 | Means and methods for treating and/or preventing natural AHR ligand-dependent cancer | US14343350 | 2012-09-07 | US09593062B2 | 2017-03-14 | Michael Platten; Christiane Opitz; Wolfgang Wick; Ulrike Litzenburger |
| The present invention relates to the field of cancer therapeutics and treatment of cancer. In particular, it relates to a method for treating and/or preventing a natural AHR ligand-dependent cancer comprising administering to a subject suffering from said cancer a therapeutically effective amount of an AHR inhibitor. Moreover, contemplated is a AHR inhibitor for use in treating and/or preventing a natural AHR ligand-dependent cancer. | ||||||
| 3 | MEANS AND METHODS FOR TREATING AND/OR PREVENTING NATURAL AHR LIGAND-DEPENDENT CANCER | US14343350 | 2012-09-07 | US20140294860A1 | 2014-10-02 | Michael Platten; Christiane Opitz; Wolfgang Wick; Ulricke Litzenburger |
| The present invention relates to the field of cancer therapeutics and treatment of cancer. In particular, it relates to a method for treating and/or preventing a natural AHR ligand-dependent cancer comprising administering to a subject suffering from said cancer a therapeutically effective amount of an AHR inhibitor. Moreover, contemplated is a AHR inhibitor for use in treating and/or preventing a natural AHR ligand-dependent cancer. | ||||||
| 4 | MEANS AND METHODS FOR TREATING AND/OR PREVENTING NATURAL AHR LIGAND-DEPENDENT CANCER | EP12758452.2 | 2012-09-07 | EP2753315A1 | 2014-07-16 | PLATTEN, Michael; OPITZ, Christiane; WICK, Wolfgang; LITZENBURGER, Ulrike |
| The present invention relates to the field of cancer therapeutics and treatment of cancer. In particular, it relates to a method for treating and/or preventing a natural AHR ligand-dependent cancer comprising administering to a subject suffering from said cancer a therapeutically effective amount of an AHR inhibitor. Moreover, contemplated is a AHR inhibitor for use in treating and/or preventing a natural AHR ligand-dependent cancer. | ||||||
| 5 | MEANS AND METHODS FOR TREATING AND/OR PREVENTING NATURAL AHR LIGAND-DEPENDENT CANCER | EP12758452.2 | 2012-09-07 | EP2753315B1 | 2017-03-01 | PLATTEN, Michael; OPITZ, Christiane; WICK, Wolfgang; LITZENBURGER, Ulrike |
| 6 | 天然AHRリガンド依存性癌を治療および/または予防するための手段および方法 | JP2014528990 | 2012-09-07 | JP6047160B2 | 2016-12-21 | プラッテン,ミヒャエル; オピッツ,クリスティアーネ; ヴィック,ヴォルフガング; リッツェンブルガー,ウルリケ |
| 7 | Means and methods for treating natural ahr ligand-dependent cancers and / or prophylaxis | JP2014528990 | 2012-09-07 | JP2014526450A | 2014-10-06 | プラッテン，ミヒャエル; オピッツ，クリスティアーネ; ヴィック，ヴォルフガング; リッツェンブルガー，ウルリケ |
| 本発明は、癌治療学および癌治療の分野に関する。 より詳細には、本発明は、天然AHRリガンド依存性癌を治療および/または予防するための方法に関するが、その方法は、前記癌に罹患した被験体に、治療上有効な量のAHR阻害剤を投与することを含む。 さらに、天然AHRリガンド依存性癌の治療および/または予防に用いるAHR阻害剤を検討する。
【選択図】なし |
||||||
| 8 | 천연 AHR 리간드-의존성 암을 치료 및/또는 예방하기 위한 수단 및 방법 | KR1020147009041 | 2012-09-07 | KR1020140074330A | 2014-06-17 | 플라텐,마이클; 오피츠,크리스티앙; 뷕,볼프강; 릿젠버거,율리케 |
| 본 발명은 암의 치료 및 암의 처치 분야에 관한 것이다. 특히, 치료학적으로 유효량의 AHR 억제제를 상기 암으로부터 고통받는 대상에 투여하는 단계를 포함하는 천연 AHR 리간드-의존성 암을 치료 및/또는 예방하기 위한 방법에 관한 것이다. 더욱이, 천연 AHR 리간드-의존성 암을 치료 및/또는 예방에서 사용하기 위한 AHR 억제제는 고려된다.
|
||||||
QQ群二维码
意见反馈
意见反馈